AOAC SPADA Meeting
Defense Biological Product Assurance Office Presented to SPADA on October 17, 2018 SPADA- In Silico Analysis Standards for Assay Development
Shanmuga Sozhamannan, Technical Coordinator, DBPAO Joint Program Executive Officer for Chemical, Biological, Radiological and Nuclear Defense This work was funded by DUSA-TE and JPEO JPM Guardian, DBPAO
UNCLASSIFIED Distribution Statement A:Approved for public release; distribution isunlimited.
Why do we need a Standard for In Silico Analysis in Assay Development?
Exorbitant cost, time and effort for developing a new assay from scratch and improving/modifying an existing assay in response to signature erosion
2018_10_17_SPADA_Brief
2
Made with FlippingBook Learn more on our blog